BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 14598015)

  • 21. Why adopt a maximin theory of exploitation?
    Wertheimer A; Millum J; Schaefer GO
    Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ethics committees in USA--background and development. Responsible conductors of clinical trials required for risk minimization].
    Lund LH
    Lakartidningen; 2008 Jan 9-15; 105(1-2):42-4. PubMed ID: 18293746
    [No Abstract]   [Full Text] [Related]  

  • 23. Ethical considerations in psychopharmacological research involving children and adolescents.
    Vitiello B
    Psychopharmacology (Berl); 2003 Dec; 171(1):86-91. PubMed ID: 12677353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does research ethics rest on a mistake? The common good, reasonable risk and social justice.
    London AJ
    Am J Bioeth; 2005; 5(1):37-9; author reply W15-8. PubMed ID: 16036656
    [No Abstract]   [Full Text] [Related]  

  • 25. [Independent Ethics Committees for clinical research in Argentina. An evaluation and a system to guarantee their independence].
    Roldán EJ
    Medicina (B Aires); 2009; 69(1 Pt 2):205-6; author reply 206. PubMed ID: 19582958
    [No Abstract]   [Full Text] [Related]  

  • 26. [Independent Ethics Committees for clinical research in Argentina. An evaluation and a system to guarantee their independence].
    Moschini J
    Medicina (B Aires); 2009; 69(1 Pt 2):204-5; author reply 205. PubMed ID: 19414309
    [No Abstract]   [Full Text] [Related]  

  • 27. The current situation regarding the establishment of national ethical guidelines for biomedical research in Thailand and its neighboring countries.
    Kojima S; Waikagul J; Rojekittikhun W; Keicho N
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):728-32. PubMed ID: 16124447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health activists attack Indian compensation formula for deaths attributed to clinical trials.
    Mudur G
    BMJ; 2013 Oct; 347():f6295. PubMed ID: 24136639
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessing benefits in clinical research: why diversity in benefit assessment can be risky.
    Churchill LR; Nelson DK; Henderson GE; King NM; Davis AM; Leahey E; Wilfond BS
    IRB; 2003; 25(3):1-8. PubMed ID: 14569987
    [No Abstract]   [Full Text] [Related]  

  • 30. Undue inducements and reasonable risks: will the dismal science lead to dismal research ethics?
    London AJ
    Am J Bioeth; 2005; 5(5):29-32. PubMed ID: 16179305
    [No Abstract]   [Full Text] [Related]  

  • 31. The sex kitten of bioethics? Research ethics comes of age.
    Resink DB
    Hastings Cent Rep; 2008; 38(5):5-6. PubMed ID: 18949856
    [No Abstract]   [Full Text] [Related]  

  • 32. Protecting the vulnerable in brain research.
    Cook-Deegan RM
    Cerebrum; 2000; 2(2):73-91. PubMed ID: 15986545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IRBs: going too far or not far enough?
    Felten DL
    Science; 2006 Sep; 313(5792):1388-9; author reply 1388-9. PubMed ID: 16959990
    [No Abstract]   [Full Text] [Related]  

  • 34. Committees for Ethics in Research involving human subjects.
    Hossne WS; Vieira S; De Freitas CB
    J Int Bioethique; 2008; 19(1-2):131-41, 200. PubMed ID: 18664006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversing "research exceptionalism".
    Hansson SO
    Am J Bioeth; 2010 Aug; 10(8):66-7. PubMed ID: 20694917
    [No Abstract]   [Full Text] [Related]  

  • 36. A time of promise, a time of promises: ethical issues in advancing psychopharmacological research.
    Roberts LW; Krystal J
    Psychopharmacology (Berl); 2003 Dec; 171(1):1-5. PubMed ID: 14615879
    [No Abstract]   [Full Text] [Related]  

  • 37. Institutional review board consideration of chart reviews, case reports, and observational studies.
    Neff MJ
    Respir Care; 2008 Oct; 53(10):1350-3. PubMed ID: 18811999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should ethics standards for overseas trials get a makeover?: Transparency in overseas medical research has improved, but several issues concerning ethics of protections for trial participants remain unsolved.
    Stone K
    Ann Neurol; 2013 Jul; 74(1):A7-A10. PubMed ID: 24038126
    [No Abstract]   [Full Text] [Related]  

  • 39. Protecting research subjects.
    Kaufman JL
    N Engl J Med; 2002 Jun; 346(26):2093-5; author reply 2093-5. PubMed ID: 12087152
    [No Abstract]   [Full Text] [Related]  

  • 40. Protection of children in research: beyond pediatric risk levels: the emergence of the research subject advocate.
    Silber TJ
    J Clin Ethics; 2010; 21(3):221-3. PubMed ID: 21089991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.